The Cancer Institute of New Jersey Foundation

blank
blank

Board of Trustees


WILLIAM WOOD ALLEN
Chief Executive Officer
WoodAllen Capital Management, LLC

PETER S. AMENTA, M.D., Ph.D.*
Dean
UMDNJ-Robert Wood Johnson Medical School

SUBHA V. BARRY
Chair
The Cancer Institute of New Jersey Foundation

THOMAS A. BRACKEN
President/CEO
New Jersey State Chamber of Commerce

COLLEEN D. BRENNAN, ESQ.
Vice President, Chief Compliance Officer
Horizon Blue Cross Blue Shield of New Jersey

ROBERT E. CAMPBELL
Chair, CINJ Advisory Council
Johnson & Johnson, Vice Chairman (Retired)

ROBERT S. DiPAOLA, M.D.*
Director
The Cancer Institute of New Jersey
Professor of Medicine
UMDNJ, Robert Wood Johnson Medical School

CHRISTIANA FOGLIO
Chief Operating Officer
Community Investment Strategies, Inc.

AUDREY GOULD
Senior Vice President
The Gould Group of Wells Fargo Advisors, LLC

WILLIAM N. HAIT, M.D., Ph.D.
Senior Vice President
Worldwide Head of Hematology/Oncology Research and Development
Johnson & Johnson Pharmaceutical Research and Development, LLC

RONALD J. LEVINE, Esq.
Partner
Herrick, Feinstein, LLP, Newark, NJ

MICHAEL E. LUBOWITZ, ESQ.
Co-head, New York Private Equity and Mergers & Acquisitions Department
Weil, Gotshal & Manges LLP

DUNCAN L. MacMILLAN
Co-Founder
Bloomberg LP

HON. EDWARD J. McKENNA, JR., Esq.
Senior Partner
McKenna, Dupont, Higgins & Stone

PAUL MIGNON
President and Chief Operating Officer
Ventiv Pharma Teams
inVentiv Commercial Services

DENISE V. RODGERS, M.D.*
Executive Vice President for Academic and Clinical Affairs
University of Medicine and Dentistry of New Jersey

RICHARD C. ROSENZWEIG, Esq.
Vice President, Law and Assistant Secretary
C.R. Bard, Inc.

LESLIE LOGAN TAYLOR
Partner
Matrix Development Group

JOHN R. WHITMAN
Managing Partner
Sycamore Management Corporation

SUSAN WOLFORD
Managing Director and Sector Head
BMO Capital Markets Business Services & Media Group

ANN M. STOCK ZAKARIA, Ph.D.
Professor
UMDNJ-Robert Wood Johnson Medical School
Associate Director
Center for Advance Biotechnology and Medicine


*Ex-Officio



blank

blank
What's New at CINJ


Vaccine Regimen that Strengthens Body's Immune Defenses Associated with Stable Disease in Treatment of Pancreatic Cancer

Functional Link Identified Between Two Causes of Breast Cancer Treatment Failure

CINJ Research on Cancer Survival Pathways has Implications for New Melanoma Therapies

Panera Bread® Raises Nearly $70K to Support Fight Against Cancer

CINJ Associate Director of Clinical Trials Given National Award

Latest Stories

Oncolyte

 

CINJF logo Click to visit the CINJ website